Although this is a DNDN MB, there are so may aspects of DNDN's Provenge and CEGE's GVAX that relate to dealing with similar issues (and the CEGE MBs are relatively inactive) that I have posted a summary of relevant clinical activity of CEGE for anyone wanting to keep track of both at: http://www1.investorvillage.com/smbd.asp?mb=247&mn=227&pt=msg&mid=3649880
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.